Stock screenerAll disclosures →
EDGAR →
ALEC
Conviction 28HealthcareScan · Tue, Oct 6, 2026Alector, Inc. (ALEC) closed at $1.80 (-9.55%) on Oct 6, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 41, RS Rating 22, -45.6% from its 52-week high, +17.6% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
ALEC$1.80-9.55%
ResistanceSupportVol 14Insider sellVol MA14 7.68M
Jul 9Jul 27Aug 13Aug 31Sep 18Oct 6
Price1.80
Change-9.55%
Gap+4.52%
Rel volume0.74×
Avg volume6.02M
Avg $ vol11.98M
SMA 201.97
SMA 502.03
SMA 2002.00
Price vs 50-11.45%
Price vs 200-9.89%
MA stackmixed
50/200 crossgolden · 6d
Supertrenddown · 2.28
RSI (14)41
MACD hist-0.02
MACD cross—
Stoch %K / %D5 / 10
ADX (14)23
+DI / −DI31 / 18
RSI divergence—
MACD divergence—
ATR %12.65%
ADR %9.70%
52w high3.31
52w low1.14
From 52w high-45.62%
Above 52w low+57.89%
New 52w highNo
SqueezeOn · 1d
Bollinger width26.16%
%B0.17
Donchian pos5.10%
Donchian high2.73
Donchian low1.75
AVWAP (52w high)1.89
vs AVWAP high-5.00%
AVWAP (52w low)2.02
vs AVWAP low-10.87%
OBV trendUp
Chaikin MF (20)-0.69
Today vs 20d0.74×
Avg vol (14d)7.68M
Avg vol (20d)6.02M
Avg $ vol (20d)11.98M
Market cap200.98M
RS Rating22 / 99
RS 3m (vs SPY)-6.16%
RS 6m (vs SPY)-45.32%
RS line new highNo
Trend template3/8
Technical rank18.2
1 week-3.74%
1 month-26.83%
3 months-1.64%
6 months-27.13%
1 year-45.78%
YTD+17.65%
P/E-1.41
P/B-20.16
P/S9.55
P/FCF-1.09
EPS-1.39
Div yield—
ROE—
ROA-70.46%
Debt/Eq-0.99
Current5.26
EV/EBITDA-1.00
Gross margin—
Net margin-679.16%
Rev growth-79.07%
EPS growth-20.06%
Price target3.30
Target upside83.33%
Analyst ratingHold
Institutional88.51%
Ent. value150.92M
Revenue3.32M
Net income-22.99M
Gross profit—
Free cash flow-184.07M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out111.03M
Employees103
ListedThu, Feb 7, 2019
Free float82.98M
Float %76.0%
Short interest6.17M
Days to cover4.6d
Short volume51.3%
Squeeze score45 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.21 vs −$0.24
Last surprise+12.5% beat
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank18.2 / 100
Group rank14 / 100
Status lane—
Setup direction—
Pattern family
Resistance2.64
Support1.85
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Morgan Stanley raises Alector stock price target on milestone credit By Investing.comInvesting.com Canada · Tue, Oct 6, 2026
- Morgan Stanley raises Alector stock price target on milestone creditInvesting.com India · Tue, Oct 6, 2026
- Mizuho reiterates Alector stock rating at Neutral on Roche dealInvesting.com · Tue, Oct 6, 2026
- Alector shares up after sealing $1.27bn Roche Parkinson’s disease license dealPharmaceutical Technology · Tue, Oct 6, 2026
- Mizuho reiterates Alector stock rating at Neutral on Roche deal By Investing.comInvesting.com UK · Tue, Oct 6, 2026
- Alector, Inc. Stock 12‑Month Price Target Raised to $3.3, Implies 66% UpsideTradingView · Tue, Oct 6, 2026
- Why is Alector stock surging today?Investing.com · Mon, Oct 5, 2026
- Update: Alector Shares Rise After Licensing AL050 Program to Roche's GenentechYahoo Finance · Mon, Oct 5, 2026
- Alector, Inc. (ALEC) stock price, news, quote and historyYahoo Finance UK · Mon, Oct 5, 2026
- Why is Alector Stock (ALEC) 60% Higher Today?TipRanks · Mon, Oct 5, 2026
Congress activity
Disclosed STOCK Act trades in ALEC
No recent disclosed trades by Congress in ALEC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ALEC
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Rosenthal Arnon Chief Executive Officer · Common Stock · 2026-08-19 | Gift | 350K | — | 2026-08-19 | 2026-08-21 |
Rosenthal Arnon Chief Executive Officer · Common Stock · 2026-08-19 | Gift | 1.05M | — | 2026-08-19 | 2026-08-21 |
Wong-Sarad Grace Principal Accounting Officer · Common Stock · 2026-07-09 | Grant | 20K | — | 2026-07-09 | 2026-07-09 |
Yaffe Kristine Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
LAVIGNE LOUIS J JR Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
LAVIGNE LOUIS J JR Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
DESOUZA ERROL B Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
DESOUZA ERROL B Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
Altmeyer Mark Director · Common Stock · 2026-06-17 | Grant | 28.7K | — | 2026-06-17 | 2026-06-17 |
Altmeyer Mark Director · Stock Option (right to buy) · 2026-06-17 | Grant | 9.45K | — | 2026-06-17 | 2026-06-17 |
SEC filings
EDGAR filings in ALEC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.